Friday, October 8, 2021 from 10:00 AM to 12:00 PM EDT
Add to Calendar 


Zoom link to be sent 


Lyn Haselton 
Meredith A. Cowden Foundation 

2021 Graft versus Host Disease

 Virtual Symposium Series 




This unique conference focuses on cutting edge research and new treatments.  Our symposia have two tracks: one designed for physicians and other health care professionals, and one for bone marrow transplant (BMT) survivors, their families and their caregivers.

The Meredith A. Cowden Foundation in collaboration with the Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center, and Cleveland Clinic Taussig Cancer Institute, created the GvHD National Symposium in 2010 to raise awareness about Graft vs. Host Disease (GvHD), to promote research to further our understanding of its cause, and to review cutting edge approaches to prevention and treatment.

Over 1,700 people have attended our events, which have provided an opportunity for attendees to interact with some of the world’s leading authorities on GvHD, a complication that affects over 60% of bone marrow transplant patients. Our past symposiums have served as invaluable experiences to learn, network and exchange ideas with each other.

Due to COVID19 restrictions, our in person meeting has been postponed to 2022. To support those with chronic graft versus host disease and those in the community, we continue our virtual symposia series with our second installment:

Friday, October 8th, 2021 at 10AM – 12PM EST

Dr. Robert Zeiser, MD

Medical Center University of Freiburg (MCUF)

“Novel Approaches to Address Chronic GVHD in Clinical Trials and Practice”

*Presentation followed by a patient-centered Q&A panel hosted by the GvHD planning committee.

We hope that you will join us for this exciting virtual event!


Thank you to our sponsors!